Style | Citing Format |
---|---|
MLA | Afsharinasab A, et al.. "Two Novel Compounds With Tri-Aryl Structures As Effectivanti-Breast Cancer Candidates In-Vivo." Iranian Journal of Pharmaceutical Research, vol. 19, no. 2, 2020, pp. 145-152. |
APA | Afsharinasab A, Moayer F, Amini M, Choopani S, Tahmasvand R, Dehghani S, Mousavi SZ, Salimi M (2020). Two Novel Compounds With Tri-Aryl Structures As Effectivanti-Breast Cancer Candidates In-Vivo. Iranian Journal of Pharmaceutical Research, 19(2), 145-152. |
Chicago | Afsharinasab A, Moayer F, Amini M, Choopani S, Tahmasvand R, Dehghani S, Mousavi SZ, Salimi M. "Two Novel Compounds With Tri-Aryl Structures As Effectivanti-Breast Cancer Candidates In-Vivo." Iranian Journal of Pharmaceutical Research 19, no. 2 (2020): 145-152. |
Harvard | Afsharinasab A et al. (2020) 'Two Novel Compounds With Tri-Aryl Structures As Effectivanti-Breast Cancer Candidates In-Vivo', Iranian Journal of Pharmaceutical Research, 19(2), pp. 145-152. |
Vancouver | Afsharinasab A, Moayer F, Amini M, Choopani S, Tahmasvand R, Dehghani S, et al.. Two Novel Compounds With Tri-Aryl Structures As Effectivanti-Breast Cancer Candidates In-Vivo. Iranian Journal of Pharmaceutical Research. 2020;19(2):145-152. |
BibTex | @article{ author = {Afsharinasab A and Moayer F and Amini M and Choopani S and Tahmasvand R and Dehghani S and Mousavi SZ and Salimi M}, title = {Two Novel Compounds With Tri-Aryl Structures As Effectivanti-Breast Cancer Candidates In-Vivo}, journal = {Iranian Journal of Pharmaceutical Research}, volume = {19}, number = {2}, pages = {145-152}, year = {2020} } |
RIS | TY - JOUR AU - Afsharinasab A AU - Moayer F AU - Amini M AU - Choopani S AU - Tahmasvand R AU - Dehghani S AU - Mousavi SZ AU - Salimi M TI - Two Novel Compounds With Tri-Aryl Structures As Effectivanti-Breast Cancer Candidates In-Vivo JO - Iranian Journal of Pharmaceutical Research VL - 19 IS - 2 SP - 145 EP - 152 PY - 2020 ER - |